Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;19(10):616.
doi: 10.1038/s41571-022-00688-0.

Synergy of EphB2 and PD-1 blockade

David Killock  1
Affiliations
Comment

Synergy of EphB2 and PD-1 blockade

David Killock. Nat Rev Clin Oncol. 2022 Oct.
No abstract available

PubMed Disclaimer

Comment on

  • EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.
    Sadeghi S, Quinn D, Dorff T, Pal S, Groshen S, Tsao-Wei D, Parikh R, Devitt M, Parikh M, Jackovich A, Ruel N, Vogelzang N, Burgess E, Siddiqi I, Gill IS, Lara PN, Dreicer R, Gill PS. Sadeghi S, et al. J Clin Oncol. 2023 Jan 20;41(3):640-650. doi: 10.1200/JCO.21.02923. Epub 2022 Aug 19. J Clin Oncol. 2023. PMID: 35984996 Clinical Trial.

References

Original article
    1. Sadeghi, S. et al. EphrinB2 inhibition and pembrolizumab in metastatic urothelial carcinoma. J. Clin. Oncol. https://doi.org/10.1200/JCO.21.02923 (2022) - DOI - PubMed

Substances

LinkOut - more resources